| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0168-8278(98)80207-9 |
| P8608 | Fatcat ID | release_hfwihm5s6vaylb5omcaxiwtop4 |
| P698 | PubMed publication ID | 9537870 |
| P50 | author | Dora Brites | Q37384611 |
| P2093 | author name string | Cardoso M | |
| Graça LM | |||
| Rodrigues CM | |||
| Oliveira N | |||
| P2860 | cites work | Steatorrhea in patients with intrahepatic cholestasis of pregnancy | Q69131881 |
| Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial | Q69357047 | ||
| Recurrent jaundice in pregnancy. 3. Quantitative determination of urinary estriol conjugates, including studies in pruritus gravidarum | Q69579552 | ||
| High-performance liquid chromatographic determination of tauro- and glyco-conjugated bile acids in human serum | Q69700424 | ||
| Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? | Q69896715 | ||
| Ursodeoxycholic acid for primary biliary cirrhosis | Q69903541 | ||
| Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration | Q71298538 | ||
| Radioimmunoassay of serum bile acids in normal pregnancy and in recurrent cholestasis of pregnancy | Q71422244 | ||
| Serum conjugated bile acid profile during intrahepatic cholestasis of pregnancy | Q72240010 | ||
| Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy | Q72581857 | ||
| Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy | Q72749250 | ||
| Serum bile acid levels in pregnancy with pruritus (bii.e acids and steroids 158) | Q72859324 | ||
| A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
| A simple and sensitive assay of total serum bile acids | Q28333896 | ||
| Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid | Q34409054 | ||
| Prevalence of Intrahepatic Cholestasis of Pregnancy in Chile | Q34708913 | ||
| Role of S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis | Q37785010 | ||
| Serum bile acid levels in intrahepatic cholestasis of pregnancy during treatment with phenobarbital or cholestyramine | Q39561709 | ||
| Effect of cholestyramine and phenobarbital on pruritus and serum bile acid levels in cholestasis of pregnancy | Q39577593 | ||
| Intrahepatic cholestasis of pregnancy with marked elevation of transaminases in a black American | Q39770494 | ||
| Pregnancy-associated idiopathic intrahepatic cholestasis. Hypotheses of physiopathology: a therapeutic case report | Q41148792 | ||
| The enigma of intrahepatic cholestasis of pregnancy: lessons from Chile. | Q41464223 | ||
| Determination of serum bile acids by glass capillary gas-liquid chromatography | Q43723825 | ||
| Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis | Q43814867 | ||
| Jaundice in pregnancy. II. Clinical course of pregnancy and delivery and condition of neonate. | Q44183420 | ||
| Separation of conjugated and unconjugated bile acids by thin-layer chromatography | Q44389049 | ||
| Vasoconstrictive effect of bile acids on isolated human placental chorionic veins | Q45155050 | ||
| Fetal outcome in obstetric cholestasis. | Q47876824 | ||
| Carbohydrate metabolism in the course of intrahepatic cholestasis in pregnancy. | Q51618840 | ||
| Epomediol ameliorates pruritus in patients with intrahepatic cholestasis of pregnancy. | Q55038108 | ||
| Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial | Q68019501 | ||
| Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy | Q68134805 | ||
| Management of intrahepatic cholestasis in pregnancy | Q68326889 | ||
| Effects of secondary bile acids on the intrauterine development in rats | Q68655540 | ||
| P433 | issue | 1 | |
| P921 | main subject | maternal health | Q6786626 |
| P304 | page(s) | 91-98 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy | |
| P478 | volume | 28 |
| Q28343505 | Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment |
| Q28141896 | Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy |
| Q44990932 | Comparison of the arrhythmogenic effects of tauro- and glycoconjugates of cholic acid in an in vitro study of rat cardiomyocytes |
| Q44688668 | Cross-talk between neurons and astrocytes in response to bilirubin: adverse secondary impacts |
| Q35182458 | Dermatoses of pregnancy - clues to diagnosis, fetal risk and therapy |
| Q44437820 | Dexamethasone and ursodeoxycholic acid protect against the arrhythmogenic effect of taurocholate in an in vitro study of rat cardiomyocytes |
| Q60632869 | Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy |
| Q93100303 | Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study |
| Q46891717 | Glycoursodeoxycholic acid reduces matrix metalloproteinase-9 and caspase-9 activation in a cellular model of superoxide dismutase-1 neurodegeneration |
| Q37288454 | In search of an accurate evaluation of intrahepatic cholestasis of pregnancy |
| Q73103956 | Intrahepatic Cholestasis of Pregnancy |
| Q21202971 | Intrahepatic cholestasis of pregnancy |
| Q83776178 | Intrahepatic cholestasis of pregnancy |
| Q37294587 | Intrahepatic cholestasis of pregnancy-current achievements and unsolved problems |
| Q34210629 | Intrahepatic cholestasis of pregnancy. |
| Q28141076 | Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management |
| Q46351593 | Obstetric cholestasis, outcome with active management: a series of 70 cases |
| Q73122648 | Pregnancy and liver disease |
| Q34140818 | Primary biliary cirrhosis with features of autoimmune hepatitis |
| Q52807234 | Relevance of serum bile acid profile in the diagnosis of intrahepatic cholestasis of pregnancy in an high incidence area: Portugal. |
| Q33723536 | Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases |
| Q35026868 | Safe prescribing practices in pregnancy and lactation |
| Q38126533 | Specific dermatoses of pregnancy and their treatment. |
| Q35992575 | The evolving landscape of neurotoxicity by unconjugated bilirubin: role of glial cells and inflammation |
| Q33681533 | There may be a link between intrahepatic cholestasis of pregnancy and familial combined hyperlipidaemia: a case report. |
| Q34797031 | Treatment of itching associated with intrahepatic cholestasis of pregnancy |
| Q60632870 | Unusual case of severe cholestasis of pregnancy with early onset, improved by ursodeoxycholic acid administration |
| Q90010033 | Ursodeoxycholic acid enriches intestinal bile salt hydrolase-expressing Bacteroidetes in cholestatic pregnancy |
| Q46504432 | Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. A 12-year experience |
| Q92394852 | Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial |
Search more.